SRm300_Srrm2 Inhibitors represents a group of compounds that exert their biological effects by targeting the splicing factor SRm300 and its interaction with the Srrm2 protein. Splicing factors play a crucial role in the regulation of alternative splicing, a process fundamental to the generation of diverse protein isoforms from a single gene. SRm300 and Srrm2 are specifically involved in this intricate molecular mechanism, where they contribute to the accurate excision of introns and the proper assembly of exons during pre-mRNA processing. The inhibitors belonging to the SRm300_Srrm2 class are designed to modulate this splicing machinery, thereby influencing the pattern of spliced RNA molecules produced within a cell.
The mechanism of action of SRm300_Srrm2 Inhibitors involves their ability to interfere with the physical interaction between SRm300 and Srrm2. By disrupting this binding, these inhibitors perturb the splicing process, leading to altered mRNA isoforms and, consequently, impacting downstream cellular functions. The development and exploration of SRm300_Srrm2 Inhibitors stem from a deeper understanding of the intricate splicing code governing gene expression. Researchers aim to harness the potential of these compounds to unravel the complex regulatory networks shaped by alternative splicing events. As investigations into the molecular intricacies of splicing continue, SRm300_Srrm2 Inhibitors offer a valuable tool for deciphering the precise roles of SRm300 and Srrm2 in cellular processes, contributing to the broader comprehension of gene expression regulation at the post-transcriptional level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Binds to SF3b complex, a crucial component of the spliceosome with which SRm300 interacts, altering splicing activity. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
Inhibits the assembly of spliceosomal complexes, impacting the splicing process where SRm300 functions. | ||||||
Madrasin | 374913-63-0 | sc-507563 | 100 mg | $750.00 | ||
Alters the core spliceosome assembly, which could affect the splicing regulation by SRm300. | ||||||
Herboxidiene | 142861-00-5 | sc-506378 | 1 mg | $1009.00 | ||
Binds to spliceosome components and may indirectly affect SRm300's role in spliceosome assembly or function. | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
Inhibits eIF4A, part of the translation initiation complex, which could indirectly affect mRNA processing involving SRm300. | ||||||